1. |
Jemal A, Bray F, Center MM, et al.Global cancer statistics[J]. CA Cancer J Clin, 2011, 61(2):69-90.
|
2. |
Gigerenzer G, Mata J, Frank R.Public knowledge of benefits of breast and prostate cancer screening in Europe[J].J Natl Cancer Inst, 2009, 101(17):1216-1220.
|
3. |
姜超, 张峰, 王少军, 等.COX-2与HIF-1α在肝癌中的表达与相关性[J].中国普外基础与临床杂志, 2006, 13(2):142-144.
|
4. |
魏学明, 顾国利, 任力, 等.胃癌组织中EGFR、C-erbB-2、VEGF及COX-2的表达及意义[J].中国普外基础与临床杂志, 2009, 16(11):900-905.
|
5. |
Da MX, Wu XT, Wang J, et al.Expression of cyclooxygenase-2 and vascular endothelial growth factor-C correlates with lymph-angiogenesis and lymphatic invasion in human gastric cancer[J].Arch Med Res, 2008, 39(1):92-99.
|
6. |
李玉民, 薛群基, 周彦明, 等.胃癌组织中环氧合酶-2的表达及其意义[J].中国普外基础与临床杂志, 2003, 10(2):137-139.
|
7. |
张宁, 陶凯雄, 王国斌, 等.环氧合酶-2及血管生成素-2在大肠癌中的表达及临床意义[J].中国普外基础与临床杂志, 2006, 13(5):564-567.
|
8. |
Matsubayashi H, Infante JR, Winter J, et al.Tumor COX-2 expression and prognosis of patients with resectable pancreatic cancer[J].Cancer Biol Ther, 2007, 6(10):1569-1575.
|
9. |
陈振栋, 谭浪平, 王亚洲, 等.角质细胞生长因子和环氧化酶-2在胃癌中的表达及其与血管生成的关系[J].中国普外基础与临床杂志, 2011, 18(2):177-182.
|
10. |
祝玉祥, 章佳新, 邵稳喜, 等.ki67在三阴性乳腺癌组织中的表达及意义[J].中国现代普通外科进展, 2010, 13(9):679-680, 697.
|
11. |
Edge SB, Byrd DR, Compton CC, et al.AJCC Cancer Staging Manual[M].7th ed.New York:Springer, 2009:643-648.
|
12. |
杨阳, 钱晓萍, 陈洁宇, 等.COX-2在乳腺癌组织的表达及其与临床病理参数的相关性[J].现代肿瘤医学, 2009, 17(8):1467-1471.
|
13. |
解兰亭, 李进岩, 刘爱东, 等.COX-2和p53在乳腺癌组织中的表达及其临床意义[J].临床外科杂志, 2009, 17(10):693-694.
|
14. |
邹天宁, 胡凤娣, 陈艳, 等.乳腺癌组织Cox-2和ERβmRNA表达及其相关性研究[J].中华肿瘤防治杂志, 2008, 15(10):758-761.
|
15. |
Oliveira VM, Piato S, Silva MA.Correlation of cyclooxygenase-2 and aromatase immunohistochemical expression in invasive ductal carcinoma, ductal carcinoma in situ, and adjacent normal epithelium[J].Breast Cancer Res Treat, 2006, 95(3):235-241.
|
16. |
刘秀静, 刘雨清.COX-2和survivin在乳腺癌组织中的表达及其相关性[J].潍坊医学院学报, 2009, 31(6):462-464.
|
17. |
Chell S, Kaidi A, Kadi A, et al.Mediators of PGE2 synthesis and signalling downstream of COX-2 represent potential targets for the prevention/treatment of colorectal cancer[J].Biochim Biophys Acta, 2006, 1766(1):104-119.
|
18. |
郭贵龙, 杨光伦, 李卓英, 等.环氧合酶-2对乳腺癌淋巴管形成的影响[J].中华外科杂志, 2008, 46(2):132-135.
|
19. |
Singh B, Cook KR, Vincent L, et al.Cyclooxygenase-2 induces genomic instability, BCL2 expression, doxorubicin resistance, and altered cancer-initiating cell phenotype in MCF7 breast cancer cells[J].J Surg Res, 2008, 147(2):240-246.
|
20. |
Gerdes J, Schwab U, Lemke H, et al.Production of a mouse monoclonal antibody reactive with a human nuclear antigen associate with cell proliferation[J].Int J Cancer, 1983, 31(1):13-20.
|
21. |
杨雪琴, 李雁.Ki67在乳腺癌的研究进展[J].武汉大学学报:医学版, 2011, 32(6):852-856.
|
22. |
钱金锋, 谢慧君, 蔡德巍, 等.Her2和Ki-67在乳腺癌中的表达和意义[J].交通医学, 2011, 25(1):28-30.
|
23. |
Yerushalmi R, Woods R, Ravdin PM, et al.Ki67 in breast cancer:prognostic and predictive potential[J].Lancet Oncol, 2010, 11(2):174-183.
|
24. |
Santisteban M, Reynolds C, Barr Fritcher EG, et al.Ki67:a time-varying biomarker of risk of breast cancer in atypical hyperplasia[J].Breast Cancer Res Treat, 2010, 121(2):431-437.
|
25. |
von Minckwitz G, Sinn HP, Raab G, et al.Clinical response after two cycles compared to HER2, Ki-67, p53, and bcl-2 in independently predicting a pathological complete response after preoperative chemotherapy in patients with operable carcinoma of the breast[J].Breast Cancer Res, 2008, 10(2):R30.
|
26. |
管小青, 吴骥, 顾书成, 等.survivin与p53、Ki67在复发转移性乳腺癌组织中表达及相关性研究[J].中国普外基础与临床杂志, 2011, 18(3):290-294.
|
27. |
谢春华, 杨基鹏, 刘峥, 等.Ki67、VEGF、nm23在乳腺癌组织中表达的相关性及临床意义[J].中国肿瘤外科杂志, 2011, 3(6):325-328.
|
28. |
Klintman M, Bendahl PO, Grabau D, et al.The prognostic value of Ki67 is dependent on estrogen receptor status and histological grade in premenopausal patients with node-negative breast cancer[J].Mod Pathol, 2010, 23(2):251-259.
|